Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-25

Clinical Trial Update: The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial assessing the safety, tolerability, and preliminary efficacy of HepaCure in Chinese patients with acute-on-chronic liver failur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HepaCure

Snippet

Sponsor: Hexaell Biotech Co., Ltd. | Conditions: Acute on Chronic Hepatic Failure, Liver Failure | Phase 1, Phase 2 | Status: RECRUITING